Assetmark Inc. Acquires 33,438 Shares of Healthpeak Properties, Inc. $DOC

Assetmark Inc. boosted its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 8.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 432,796 shares of the real estate investment trust’s stock after acquiring an additional 33,438 shares during the period. Assetmark Inc. owned about 0.06% of Healthpeak Properties worth $6,959,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also modified their holdings of DOC. JPMorgan Chase & Co. lifted its position in shares of Healthpeak Properties by 41.0% during the third quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock valued at $540,730,000 after buying an additional 8,212,504 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Healthpeak Properties by 694.6% in the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock valued at $153,520,000 after purchasing an additional 7,007,777 shares during the last quarter. Equity Investment Corp raised its position in shares of Healthpeak Properties by 209.6% in the 3rd quarter. Equity Investment Corp now owns 5,330,948 shares of the real estate investment trust’s stock valued at $102,088,000 after purchasing an additional 3,608,849 shares during the last quarter. Bank of America Corp DE raised its position in shares of Healthpeak Properties by 28.5% in the 3rd quarter. Bank of America Corp DE now owns 9,936,934 shares of the real estate investment trust’s stock valued at $190,292,000 after purchasing an additional 2,206,222 shares during the last quarter. Finally, Russell Investments Group Ltd. raised its position in shares of Healthpeak Properties by 176.4% in the 3rd quarter. Russell Investments Group Ltd. now owns 3,063,569 shares of the real estate investment trust’s stock valued at $58,663,000 after purchasing an additional 1,955,273 shares during the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.

Healthpeak Properties Price Performance

Healthpeak Properties stock opened at $17.34 on Friday. The company’s fifty day moving average price is $17.03 and its 200 day moving average price is $17.32. Healthpeak Properties, Inc. has a 1 year low of $15.71 and a 1 year high of $19.68. The stock has a market capitalization of $12.05 billion, a P/E ratio of 173.37, a P/E/G ratio of 2.37 and a beta of 1.10. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.82 and a current ratio of 2.82.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.45 by $0.02. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. The firm had revenue of $719.40 million for the quarter, compared to analysts’ expectations of $685.14 million. During the same quarter last year, the company earned $0.46 EPS. The firm’s revenue for the quarter was up 3.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, equities research analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 15th will be issued a $0.1017 dividend. The ex-dividend date is Monday, June 15th. This represents a c) dividend on an annualized basis and a yield of 7.0%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 1,220.00%.

Wall Street Analyst Weigh In

DOC has been the subject of several research analyst reports. Citigroup decreased their price objective on shares of Healthpeak Properties from $18.00 to $17.50 and set a “neutral” rating for the company in a research report on Wednesday, April 1st. Weiss Ratings raised shares of Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, January 26th. The Goldman Sachs Group started coverage on shares of Healthpeak Properties in a research report on Friday, January 9th. They issued a “neutral” rating and a $17.00 price objective for the company. Wells Fargo & Company reiterated a “positive” rating on shares of Healthpeak Properties in a report on Tuesday, February 3rd. Finally, Argus downgraded shares of Healthpeak Properties from a “buy” rating to a “hold” rating in a report on Thursday, February 5th. Six analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $19.19.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.